ArticlePDF Available

Morbidity of central compartment clearance: Comparison of lesser versus complete clearance in patients with thyroid cancer

Authors:

Abstract and Figures

Background: Extent of central compartment neck dissection (CCND) in thyroid cancers has been a debate because of associated morbidity. There have been attempts to reduce the extent of surgery in an attempt to decrease morbidity. Patients and Methods: We analyzed the morbidity of CCND from our prospectively maintained surgical morbidity database. CCND was divided into bilateral complete clearance (BCC) and less than complete clearance (LCC). LCC was performed for clinicoradiologically node negative patients. Rates of hypocalcemia and recurrent laryngeal nerve (RLN) palsy rates were compared for LCC versus BCC. We also classified procedures performed in the central neck according to the extent of dissection. Results: Of 153 evaluable patients, BCC was performed in 43.8% and LCC in 56.2%. Rate of postoperative hypocalcemia was 40.2% in BCC group versus 17.4% in LCC group. We had an overall RLN palsy rate of 7.4%. There was no significant difference in RLN palsy rates between the groups. Conclusion: Lesser extent of dissection in central compartment reduces postoperative hypocalcemia but has no influence on RLN palsy rates.
Content may be subject to copyright.
102 © 2017 Journal of Cancer Research and Therapeutics | Published by Wolters Kluwer - Medknow
Gouri Pantvaidya,
Rakesh Katna,
Anuja Deshmukh,
Deepa Nair,
Anil D’Cruz
DepartmentofHead
andNeckSurgery,Tata
MemorialHospital,
Mumbai,Maharashtra,
India
For correspondence:
Dr.GouriPantvaidya,
Departmentof
HeadandNeck
Oncosurgery,Tata
MemorialHospital,
Parel,Mumbai,
Maharashtra,India.
E-mail:docgouri@
gmail.com
Morbidity of central compartment
clearance: Comparison of lesser versus
complete clearance in patients with thyroid
cancer
ABSTRACT
Background: Extent of central compartment neck dissection (CCND) in thyroid cancers has been a debate because of associated
morbidity. There have been attempts to reduce the extent of surgery in an attempt to decrease morbidity.
Patients and Methods: We analyzed the morbidity of CCND from our prospectively maintained surgical morbidity database. CCND was
divided into bilateral complete clearance (BCC) and less than complete clearance (LCC). LCC was performed for clinicoradiologically
node negative patients. Rates of hypocalcemia and recurrent laryngeal nerve (RLN) palsy rates were compared for LCC versus BCC.
We also classified procedures performed in the central neck according to the extent of dissection.
Results: Of 153 evaluable patients, BCC was performed in 43.8% and LCC in 56.2%. Rate of postoperative hypocalcemia was
40.2% in BCC group versus 17.4% in LCC group. We had an overall RLN palsy rate of 7.4%. There was no significant difference
in RLN palsy rates between the groups.
Conclusion: Lesser extent of dissection in central compartment reduces postoperative hypocalcemia but has no influence on RLN
palsy rates.
KEY WORDS: Central compartment clearance, neck dissection, papillary thyroid cancer, thyroid cancer
Original Article
INTRODUCTION
Differentiated thyroid cancers (DTC) constitute
90% of all thyroid cancers and carry an excellent
long‑term prognosis.[1] The long survival rates
mandate that the quality of life in these patients
is optimal with minimum morbidity of treatment.
The incidence of lymph node metastases is high
in patients with papillary thyroid cancers (PTCs)
ranging from 45% to 60%. Clinical examination
will detect metastases in approximately 10%–15%
of these patients.[2] However, occult central
compartment nodal disease is seen in a much higher
number of patients. Central compartment disease
has been consistently shown to be associated with
increased incidence of locoregional recurrences.[3‑5]
Current standard of care for central compartment
disease is “central compartment clearance (CCC)
from the hyoid superiorly to innominate artery
inferiorly and from carotid to carotid”. However,
the need for such extensive nodal clearance in all
patients with DTC is a matter of debate, because of
the need to balance the associated morbidity and
better disease control.
The main morbidity associated with CCC is
hypocalcemia (postoperative and permanent)
and recurrent laryngeal nerve (RLN) paralysis.
Attempts have been made to decrease the extent
of surgical procedures in the central compartment.
These have been mainly in the form of avoiding
prophylactic CCC in low risk, node negative patients
or performing unilateral procedures for lateralized
lesions.[6,7] However, there is a dearth of prospective
data evaluating morbidity after lesser surgical
procedures. Does performing lesser procedures
in the central compartment actually translate
into lesser morbidity, is not known. We therefore
decided to evaluate the morbidity of CCC when a Access this article online
Website: www.cancerjournal.net
DOI: 10.4103/0973-1482.199378
PMID: ***
Quick Response Code:
This is an open access article distributed under the terms of the Creative Commons
Attribution‑NonCommercial‑ShareAlike 3.0 License, which allows others to remix,
tweak, and build upon the work non‑commercially, as long as the author is credited
and the new creations are licensed under the identical terms.
For reprints contact: reprints@medknow.com
Cite this article as: Pantvaidya G, Katna R, Deshmukh A, Nair D, D’Cruz A. Morbidity of central compartment clearance:
Comparison of lesser versus complete clearance in patients with thyroid cancer. J Can Res Ther 2017;13:102-6.
[Downloaded free from http://www.cancerjournal.net on Tuesday, May 23, 2017, IP: 2.88.216.121]
Pantvaidya, et al.: Morbidity of central compartment clearance in thyroid cancer
103
Journal of Cancer Research and Therapeutics - Volume 13 - Issue 1 - January-March 2017
“less than complete clearance” (LCC) was done as compared
to a “bilateral complete clearance” (BCC) in patients with DTC.
PATIENTS AND METHODS
A 30 days morbidity database of all patients undergoing thyroid
surgery was prospectively maintained from January 2012 to
December 2012. We retrospectively analyzed the morbidity
associated with thyroid surgery and central compartment
dissection from this prospective database.
During surgery, all central compartments were divided into
ipsilateral and contralateral compartments depending upon
the laterality of the cancer in the two lobes of the thyroid and
using the trachea as a midline to divide these compartments.
The pretracheal and prelaryngeal nodes were included in the
ipsilateral central compartment. We classified the different
surgical procedures in each central compartment as follows:
• Clearance was defined as “Complete nodal and soft tissue
clearance from carotid artery laterally till trachea in
midline with pretracheal and prelaryngeal clearance and
superiorly from hyoid to innominate artery inferiorly”
• Sampling was defined as “Nodal tissue clearance along
RLNs (paratracheal tissue)”
• Inspection was defined as “Visual inspection and palpation
of central compartment for any enlarged nodes.”
“Berry picking” is not practiced at our institute for central
compartment disease. The indications for the various surgical
procedures in the central compartment are detailed in Table 1.
Patients with histology other than DTC, those who underwent
hemithyroidectomy and patients in whom the central
compartment was not addressed, were excluded from
the analysis. Patients who underwent unilateral central
compartment dissection were also excluded from final
analysis as morbidity in these patients would be minimal
and not comparable to patients having bilateral procedures.
Hypocalcemia and RLN paralysis within 30 days postsurgery
was documented. For hypocalcemia, symptomatology in
the form of tingling numbness and a positive Chovstek’s
sign was considered as clinical hypocalcemia.[8] The serum
calcium levels were done 48–72 h postsurgery. Patients
with serum calcium levels <8.5 mg/dl were considered as
having biochemical hypocalcemia. Patients were classified
as having clinical (C), biochemical (B), or a combination of
clinical and biochemical (C + B) hypocalcemia. For assessing
recurrent laryngeal dysfunction, patients underwent
indirect laryngoscopy to assess cord mobility in the 30 days
postoperative period.
Clinicopathological parameters documented were as follows;
age, sex, previous surgery for thyroid, type of surgery, tumor
histology, pathological central compartment node positivity,
and nodal yield in central compartment.
Parathyroid glands were saved whenever possible and auto
transplanted as and when required.
Analysis
We broadly classified central compartment neck
dissection (CCND) into two groups for analysis according to
the extent of surgical dissection in each central compartment.
The two groups which were formed were “Bilateral
Complete Clearance (BCC)” and “Less than Complete
Clearance (LCC)” [Figure 1]. The BCC group had clearance done
on both sides of the trachea i.e., from hyoid to innominate
and from carotid to carotid. The LCC group had both central
compartments addressed in one of the ways described in
Figure 1. The two groups were compared for nodal yield and
pathological node positivity on final histology. The morbidity
with regard to hypocalcemia and RLN injury was compared
between the two groups.
Statistical analysis was performed using SPSS 19.0
software (SPSS, Inc., Chicago, IL, USA). Categorical data was
compared using Chi‑square analysis. Univariate analysis was
performed and any value of P < 0.05 was considered to be
statistically significant.
Figure 1: Classicationofcentralcompartmentneckdissectionfor
analysis
Table1:TataMemorialHospitalclassicationofproceduresinthecentralcompartmentwiththeirrespectiveindications
Procedure in central
compartment
Description Indications
Inspection “Visual inspection and palpation of central compartment for
enlarged nodes”
cN0 patients
Early thyroid tumors
Sampling “Nodal tissue clearance along recurrent laryngeal
nerves (paratracheal tissue)”
Node negative on USG
Enlarged nodes intraoperatively
T4 tumors with extrathyroidal extension
Clearance (unilateral) “Complete nodal and soft tissue clearance from carotid
artery laterally till trachea in midline with pretracheal and
prelaryngeal clearance upto the innominate artery inferiorly”
Node positive on preoperative USG or intraoperatively
cN0=Clinically node negative, USG=Ultrasonography
[Downloaded free from http://www.cancerjournal.net on Tuesday, May 23, 2017, IP: 2.88.216.121]
Pantvaidya, et al.: Morbidity of central compartment clearance in thyroid cancer
104 Journal of Cancer Research and Therapeutics - Volume 13 - Issue 1 - January-March 2017
RESULTS
Demographic details
Two hundred sixty‑two patients underwent thyroid surgery at
our institute in year 2012. Of these, 57 patients were excluded
because they underwent a hemithyroidectomy or had benign/
other histology. Fifty‑two patients who had either bilateral
central compartment inspection alone or unilateral central
compartment dissection performed were excluded and finally
153 patients were analyzed. The selection of patients according
to the inclusion and exclusion criteria is shown in Figure 2.
As mentioned previously, each patient had a unilateral and
contralateral central compartment which was addressed.
Therefore, 306 central compartments were addressed in
153 patients in the study. Of these, 66 central compartments
were inspected, 37 were sampled and 203 were cleared. The
demographic and treatment details for the patients are shown
in Table 2.
Central compartment neck dissection: Bilateral complete
clearance versus less than complete clearance
BCC was performed in 43.8% patients and LCC in 56.2%
patients. Mean number of nodes retrieved in BCC group was
6.2 (range 1–29), whereas in LCC group, it was 3.4 (range 1–14).
Central compartment nodes were positive in 56.2% patients
on final histology. Nodes positive on histology (pN+) in BCC
group were seen in 46/67 (68.6%) patients and in 40/86 (46.5%)
patients in the LCC group. Seventeen patients did not have a
clearance in bilateral compartments i.e., only inspection or
sampling was done in bilateral central compartments. Only
one of 17 such patients had a positive node, indicating that
inspection and sampling was done for node negative patients
only. However, among the patients who underwent bilateral
clearance, 31% were node negative on histology and may not
have required such extensive clearance.
Morbidity of central compartment neck dissection
Overall 27.4% patients had postoperative hypocalcemia.
Clinical hypocalcemia was documented in 7 patients,
biochemical hypocalcemia in 9 patients, and combined clinical
and biochemical hypocalcemia in 26 patients. In the BCC group,
rate of postoperative hypocalcemia was 40.2% compared to
17.4% in the LCC group, which was significant on univariate
analysis (P = 0.002).
Five RLNs were sacrificed intraoperatively because of gross
involvement by disease. These five patients have not been
included in the analysis of postoperative RLN paralysis.
Eleven patients had postoperative RLN palsy (7.4%). The
RLN palsy rate was 3.4% if RLNs at risk were considered for
the analysis.
Among these 11 patients with RLN paralysis, 10 patients had
multiple nodes positive in the central compartment. In two
of these patients, the nodal disease was shaved off the nerve,
and in another three patients, there was documented excess
handling of the RLN to remove the nodal disease.
On comparing the two groups; The BCC group had RLN palsy
rate of 4.4% compared to 9.3% in LCC group (P = 0.21). The LCC
group had higher number of recurrent surgical explorations
as compared with the BCC group, i.e., 36 (42%) versus
17 (25%); (P = 0.01). To explain the higher incidence of RLN
palsy in the LCC group, we evaluated only per primum cases.
However, even with the exclusion of cases undergoing redo
surgeries, the RLN palsy rate was higher in the LCC group as
compared to the BCC group (14.5% vs. 2%).
DISCUSSION
CCND in DTC has been a matter of controversy because
of associated morbidity, especially in the clinically node
negative (cN0) patient. American Thyroid Association (ATA)
recommendations for CCND are not based on level I evidence
but on large retrospective studies or nonrandomized
Figure 2: Flow chart depicting selection of patients
Table 2: Demographic details of the patient population
Variable n (%)
Mean age 41 years (13-84)
Sex (male:female) 1:1.6
T staging
Tx 32
T1 28
T2 51
T3 25
T4 17
Nodal staging
N0 59
N1a 10
N1b 84
Procedure performed (%)
Total thyroidectomy 100 (65.3)
Completion thyroidectomy 30 (19.6)
Thyroid bed exploration 13 (8.4)
Central compartment dissection 10 (6.5)
Previous surgical intervention 53 (34.6)
Histology (%)
PTC 118 (77.2)
FVPTC 34 (22.2)
Follicular carcinoma 1 (0.6)
PTC=Papillary thyroid carcinoma, FVPTC=Follicular variant of papillary thyroid
carcinoma
[Downloaded free from http://www.cancerjournal.net on Tuesday, May 23, 2017, IP: 2.88.216.121]
Pantvaidya, et al.: Morbidity of central compartment clearance in thyroid cancer
105
Journal of Cancer Research and Therapeutics - Volume 13 - Issue 1 - January-March 2017
prospective data.[9] The extent of surgical clearance within the
central compartment is not yet standardized and often based
on the surgeon’s discretion.
The controversy on the extent of neck dissection stems
from many issues such as division of a anatomically single
central compartment into an ipsilateral and contralateral
compartment, need for complete dissection from carotid to
carotid and hyoid to innominate in all cases. The ATA guidelines
define CCND as clearance of at least one paratracheal region
with the prelaryngeal, pretracheal nodes.[9] Most surgeons
use a combination of procedures depending on preoperative
node positivity, intraoperative findings after inspection of
the central compartment and poor prognostic features of the
thyroid malignancy.
At our institute, we have tried to define the various extents
of surgical procedures in the central compartment along
with their indications. We defined sampling as removal of
the nodes and fibrofatty tissue medial to the RLN. This would
potentially prevent the injury and vascular compromise to
the parathyroid glands as the inferior thyroid artery would
provide blood supply to the lower parathyroid gland from the
lateral aspect of the gland.
We prospectively documented the morbidity with regard
to RLN paralysis and hypocalcemia when these procedures
were performed. The main hypothesis behind performing less
than a complete bilateral clearance is to decrease morbidity
associated with extensive bilateral dissections. To the best of
our knowledge, there are no studies in literature, which have
prospectively tested this hypothesis. Whether performing
less surgery in the central compartment really reduces
complications of RLN paralysis and hypocalcemia is unknown.
In our study, inspection and sampling were only performed on
patients who were clinicoradiologically node negative. Only
one of the17 patients who underwent these procedures had a
positive node on histopathology. Needless to say, this cannot
be applied to patients who underwent inspection alone as
no tissue was submitted for histopathology and a true node
negative status in these central compartments can only be
confirmed on long‑term follow‑up.
Central compartment nodes were positive in 56.2% patients
on final histopathology which is similar to the reports in
literature.[10] The nodal positivity rates varied in the two
groups (BCC ‑ 68.6% vs. LCC ‑ 46.5%) expectedly so, as more
patients with positive lymph nodes underwent a BCC. Nodal
yield may act as an indirect marker of adequacy of CCC
though this has not been very well validated. There are few
studies which have reported nodal yield in CCND to around
5–6 nodes.[11,12] Similarly, in a large retrospective series of
PTC, CCND was defined as adequate if there were a minimum
number of 5 nodes on histology.[13] When we looked at the
nodal yield in our two defined groups, we found that mean
number of nodes retrieved in BCC group was 6.2 compared
to 3.4 in LCC group.
Incidence of postoperative hypocalcemia in our cohort was
27.4%, which is in range reported in literature across various
studies.[14‑16] The incidence of postoperative hypocalcemia
was significantly lower in LCC group (P = 0.002). However
the impact of this on the permanent hypocalcemia rate is not
known from this study as we have not included long term follow
up of these patients. It may therefore not be justified to use
lower rates of temporary hypocalcemia as a reason to perform
lesser CCCs. Similar findings of lower hypocalcemia have also
been documented by Moo et al. in a study looking at results of
ipsilateral versus bilateral CCC.[17] In another study by Giordano
et al., both temporary and permanent hypoparathyroidism
was significantly higher in the bilateral clearance group as
compared to the ipsilateral clearance group.[18]
Incidence of permanent RLN paralysis in total thyroidectomy
with CCND has been documented to be 1%–12% by various
authors.[11,18‑20] Most of these studies are retrospective in nature
and may underreport RLN paralysis if routine postoperative
evaluation in all patients, irrespective of symptomatology, is
not done. We report a RLN paralysis rate of 7.4% in our series.
When we compared performing lesser central clearances to
a complete bilateral clearance, we found that there was no
difference in the RLN palsy. In a metanalysis by Zhu et al., there
were no significant differences in temporary or permanent
vocal cord paralysis rates when comparing no central
compartment dissection versus prophylactic node dissection
in node negative patients.[21] A similar finding was noted in a
study by Giordano et al., where they retrospectively evaluated
RLN palsy rates comparing ipsilateral clearance versus
bilateral clearance. They too found no difference in their
palsy rates.[18] Contrary to the hypothesis that lesser surgery
would result in lesser morbidity, we found no difference in
RLN palsy rates.
CONCLUSION
Lesser surgery or avoidance of prophylactic surgery in the
central compartment is being advocated in an attempt to
decrease the morbidity in a cancer where survival outcomes
are extremely favorable. However, this hypothesis has not
been adequately studied. There appears to be a definite
decrease in the rates of temporary hypoparathyroidism when
lesser procedures are performed in the central compartment.
However, its effect on permanent hypoparathyroidism is
not known. RLN palsy rates do not seem to be any different
when lesser procedures are performed. Good technique of
dissection of the RLN is probably of utmost importance,
irrespective of whether unilateral or bilateral procedures are
being performed. To help standardize reporting of central
compartment procedures, we recommend reporting unilateral
versus bilateral procedures and classifying each of these
procedures as per our classification system.
[Downloaded free from http://www.cancerjournal.net on Tuesday, May 23, 2017, IP: 2.88.216.121]
Pantvaidya, et al.: Morbidity of central compartment clearance in thyroid cancer
106 Journal of Cancer Research and Therapeutics - Volume 13 - Issue 1 - January-March 2017
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
REFERENCES
1. Shaha AR. Implications of prognostic factors and risk groups in
the management of differentiated thyroid cancer. Laryngoscope
2004;114:393‑402.
2. Shaha AR, Shah JP, Loree TR. Patterns of nodal and distant metastasis
based on histologic varieties in differentiated carcinoma of the
thyroid. Am J Surg 1996;172:692‑4.
3. Mazzaferri EL. Papillary thyroid carcinoma: Factors influencing
prognosis and current therapy. Semin Oncol 1987;14:315‑32.
4. Hughes CJ, Shaha AR, Shah JP, Loree TR. Impact of lymph node
metastasis in differentiated carcinoma of the thyroid: A matched‑pair
analysis. Head Neck 1996;18:127‑32.
5. Mazzaferri EL, Jhiang SM. Long‑term impact of initial surgical and
medical therapy on papillary and follicular thyroid cancer. Am J Med
1994;97:418‑28.
6. Raffaelli M, De Crea C, Sessa L, Giustacchini P, Revelli L, Bellantone C,
et al. Prospective evaluation of total thyroidectomy versus ipsilateral
versus bilateral central neck dissection in patients with clinically
node‑negative papillary thyroid carcinoma. Surgery 2012;152:957‑64.
7. Randolph GW. Papillary cancer nodal surgery and the advisability of
prophylactic central neck dissection: Primum, non nocere. Surgery
2010;148:1108‑12.
8. Hoffman E. The Chvostek sign; a clinical study. Am J Surg
1958;96:33‑7.
9. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid
Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM,
Haugen BR, Kloos RT, Lee SL, et al. Revised American Thyroid
Association management guidelines for patients with thyroid
nodules and differentiated thyroid cancer. Thyroid 2009;19:1167‑214.
10. Mirallié E, Visset J, Sagan C, Hamy A, Le Bodic MF, Paineau J.
Localization of cervical node metastasis of papillary thyroid
carcinoma. World J Surg 1999;23:970‑3.
11. Sywak M, Cornford L, Roach P, Stalberg P, Sidhu S, Delbridge L.
Routine ipsilateral level VI lymphadenectomy reduces postoperative
thyroglobulin levels in papillary thyroid cancer. Surgery
2006;140:1000‑5.
12. Hughes DT, White ML, Miller BS, Gauger PG, Burney RE, Doherty GM.
Influence of prophylactic central lymph node dissection on
postoperative thyroglobulin levels and radioiodine treatment in
papillary thyroid cancer. Surgery 2010;148:1100‑6.
13. Grant CS, Stulak JM, Thompson GB, Richards ML, Reading CC, Hay ID.
Risks and adequacy of an optimized surgical approach to the primary
surgical management of papillary thyroid carcinoma treated during
1999‑2006. World J Surg 2010;34:1239‑46.
14. Palestini N, Borasi A, Cestino L, Freddi M, Odasso C, Robecchi A.
Is central neck dissection a safe procedure in the treatment of
papillary thyroid cancer? Our experience. Langenbecks Arch Surg
2008;393:693‑8.
15. Witt RL, McNamara AM. Prognostic factors in mortality and morbidity
in patients with differentiated thyroid cancer. Ear Nose Throat J
2002;81:856‑63.
16. Cheah WK, Arici C, Ituarte PH, Siperstein AE, Duh QY, Clark OH.
Complications of neck dissection for thyroid cancer. World J Surg
2002;26:1013‑6.
17. Moo TA, Umunna B, Kato M, Butriago D, Kundel A, Lee JA, et al.
Ipsilateral versus bilateral central neck lymph node dissection in
papillary thyroid carcinoma. Ann Surg 2009;250:403‑8.
18. Giordano D, Valcavi R, Thompson GB, Pedroni C, Renna L, Gradoni P,
et al. Complications of central neck dissection in patients with
papillary thyroid carcinoma: Results of a study on 1087 patients and
review of the literature. Thyroid 2012;22:911‑7.
19. Roh JL, Park JY, Park CI. Total thyroidectomy plus neck dissection in
differentiated papillary thyroid carcinoma patients: Pattern of nodal
metastasis, morbidity, recurrence, and postoperative levels of serum
parathyroid hormone. Ann Surg 2007;245:604‑10.
20. Henry JF, Gramatica L, Denizot A, Kvachenyuk A, Puccini M,
Defechereux T. Morbidity of prophylactic lymph node dissection in
the central neck area in patients with papillary thyroid carcinoma.
Langenbecks Arch Surg 1998;383:167‑9.
21. Zhu W, Zhong M, Ai Z. Systematic evaluation of prophylactic neck
dissection for the treatment of papillary thyroid carcinoma. Jpn J
Clin Oncol 2013;43:883‑8.
[Downloaded free from http://www.cancerjournal.net on Tuesday, May 23, 2017, IP: 2.88.216.121]
... One such study is by Pereira et al., where a transient RLN palsy rate of 13.3% was found when CC had metastatic nodes [25]. In another study from our own institution, on a different set of 153 patients of thyroid carcinoma who underwent surgery with CC neck dissection, out of the 11 RLN palsies in the series, 10 had positive central compartment nodes [26]. ...
Article
Full-text available
Background: Postoperative recurrent laryngeal nerve (RLN) palsy is one of the major morbidities encountered after thyroid surgery. The risk further increases when surgery is performed for thyroid malignancies. Methodology: A retrospective study of patients who underwent hemi, total or completion thyroidectomy at our institute between June 2017 to May 2019 were analyzed. We assessed factors that predisposed to the development of RLN palsy. Results: The study comprised of 228 patients. A total of 400 nerves were at risk. The RLN palsy rate was 6.8% (n = 27). On univariate and multivariate analysis, the risk of RLN palsy was seen most with pT4a tumor (OR = 8.5), gross extra-thyroidal extension (ETE) (OR = 3.5) and tracheo-esophageal groove (TEG) (OR = 2.8) involvement, followed by aggressive histopathology, and central compartment node positivity. Conclusion: pT4a tumors, gross ETE, and TEG involvement were the leading causes predisposing for the development of RLN palsy in our series.
... The rate of hypocalcemia was 40.2% in bilateral and 17.4% in lesser clearance group. [34] Various studies have reported vocal cord palsy rates of 2%-15%. [35][36][37][38] Vocal cord palsy is under-reported in the literature because many do not document the palsy in asymptomatic patients with undetected injury of RLN. ...
Article
Background: Surgery is the mainstay in the management of thyroid cancer. Surgical outcomes need to be tempered against the excellent prognosis of the disease. Aims: This study aims to study the surgical outcomes including the 30-day morbidity and 5-year survival of thyroid cancer patients. Settings and design: Retrospective analysis of a prospectively maintained surgical database in a tertiary cancer center in India. Materials and methods: We analyzed 221 surgically treated patients in the year 2012. Statistical analysis: Used IBM SPSS 24.0 (Armonk, NY) with p < 0.05. Results: The median age was 40 years with predominantly papillary thyroid carcinoma (55%). Localized disease in 47% of cases, locoregional disease in 42.5% and distant metastasis in 10.2% of cases at presentation was noted. Treatment naïve patients were 71% and revision surgeries were done in 29% patients. Extended thyroidectomy constituted 11% of the surgeries. Temporary hypocalcemia was seen in 30.8% of patients, 5% requiring intravenous calcium supplementation. Vocal cord palsy as per nerve at risk and chyle leak were seen in 4.5% and 3.1%, respectively. Aggressive histology, extended thyroidectomy, and inadvertent parathyroidectomy were significant factors associated with complications. Five year estimated overall survival with median follow-up of 50 months was 98%, and event-free survival was 84.8%. Advanced age, distant metastasis at presentation and aggressive histology connoted poor outcomes. Conclusion: Thyroid cancer, irrespective of the extent of disease, has good prognosis. Aggressive histology, the extent of thyroid surgery, distant metastasis and age are important factors, which should be factored in the algorithm of thyroid cancer management.
Article
Surveillance strategies in differentiated thyroid cancers (DTCs) differ from other head-and-neck subsites by virtue of their excellent prognosis. Guidelines in this chapter are based on a comprehensive literature review, particularly in the Indian setting concurred upon by experts in the field. Key recommendations include serial measurement of thyroglobulin values, thyroglobulin antibodies, and risk-based suppression of thyroid-stimulating hormone during follow-up of treated DTCs, with radioactive iodine scan and structural imaging based on dynamic risk stratification. These recommendations take into consideration prevailing Indian scenario related to reliability of follow-up, insurance coverage, as well as burden on health-care systems.
Article
Thyroid cancers frequently metastasize to neck nodes. However, most of these are occult micrometastases with no impact on survival, while only a small percentage have clinically apparent neck nodes. The impact of nodal metastases on overall survival is very low, as compared to other head-neck sites and pathologies. Hence the surgical management of neck nodes has to be balanced with the likely morbidity of these procedures. This narrative review deals with the management of neck nodal metastasis of well differentiated thyroid cancers.
Article
Existing guidelines recommend lobectomy/hemithyroidectomy (HT) for low-risk thyroid cancer. They are considered safer with lesser complications compared to total thyroidectomy. However, HT is also associated with certain complications. We conducted this retrospective clinical audit of all patients who underwent HT for DTC in our institute from January 2012 to December 2018. The aim of the study was to assess the complications following HT and the follow-up of these patients subsequently. A total of 128 patients satisfied the eligibility criteria. The majority of the patients were women (n = 103, 80.5%). The median age of the patients was 36.5 years (range: 19–77 years). Neck swelling was the most common presentation. All patients underwent conventional open hemithyroidectomy. Five patients had 1–2 metastatic nodes in the central compartment; however, none had metastatic nodes in the lateral neck. Biochemical hypocalcemia (n = 16, 12.5%) was the most common postoperative complication followed by recurrent laryngeal nerve palsy (n = 5, 3.9%). Twenty-six patients developed hypothyroidism at a median duration of 6.5 months following HT necessitating replacement therapy. None of the patients developed recurrence during follow-up (median of 27.5 months). HT is a feasible treatment option for patients with carefully selected cases of DTC. However, HT is also associated with certain complications that should be kept in mind, and patients should be counseled accordingly.
Article
Full-text available
To date, in patients with differentiated thyroid cancer, central neck dissection is recommended in the presence of central compartment lymph node metastases. Differently, the efficacy of prophylactic central neck dissection in case of clinically node-negative differentiated thyroid carcinoma remains still uncertain. There are many arguments in favor and many against the execution of this surgical procedure. The most recent literature and latest guidelines have been reviewed and illustrated, paying particular attention to currently hottest and most discussed points. Prophylactic central neck dissection is associated with higher rates of postoperative complications, such as recurrent laryngeal nerve injury and hypoparathyroidism, with unclear oncological benefits. Thus, in the absence of lymph node involvement, this procedure should be avoided, reserving it for high-risk patients with advanced primary tumors. Moreover, to avoid serious complications, prophylactic central neck dissection should be performed by high-volume surgeons. KEY WORDS: Clinically node-negative differentiated thyroid cancer, Differentiated thyroid carcinoma, Prophylactic central neck dissection.
Article
Full-text available
Central compartment clearance (CCC) for Papillary thyroid cancers (PTC) is one of the factors causing postoperative hypocalcaemia. We aimed to examine determinants of this major sequela. 41 patients treated for PTCs between 2014 and 2016 were studied. Surgical details, tumour and nodal characteristics, incidence of transient, temporary and permanent hypocalcaemia were noted. Central clearance was done bilaterally in 24 (58.5%) cases, ipsilaterally in 17 (41.6%). Central nodes were involved in 26 (63.4%) cases, unilaterally in 15 (36.6%), bilaterally in 11 (26.8%). Transient hypocalcaemia developed in 10 (24.4%) cases, temporary hypocalcaemia in 6 (14.6%) cases, and permanent hypocalcaemia in 2 (4.9%) cases. 17 (41%) patients were symptomatic. 9 (21.9%) patients received intravenous calcium. The only factor consistently associated with development of hypocalcaemia of all patterns, was the presence of matted central compartment nodes (p = 0.021). Matted nodes also related to a longer length of stay (p = 0.04) and requirement of intravenous calcium (p = 0.000). Extent of CCC, nodal yield, nodal positivity, perinodal extension, number of parathyroids identified, gender or pT size were not significantly associated. Symptomatic patients did not necessarily become permanently hypocalcaemic (p = 0.8). Patients requiring intravenous calcium were more likely to take oral calcium after discharge (p = 0.002). Postoperative hypocalcaemia is more likely in cases with bulky involved central nodes where extensive clearance is done. In routine CCC, even if done bilaterally, preservation of parathyroid function is possible. Permanent hypocalcaemia after CCC need not be taken as inevitable.
Chapter
Die Krankheitsdynamik maligner Schilddrüsentumoren variiert stark. Daher kann die palliative Phase unterschiedlich lang sein. So entsteht ein Patientenkollektiv, das zwar nicht mehr kurativ behandelt werden kann, aber unter palliativer Therapie eine respektable Lebenserwartung hat. Therapeutisches Vorgehen sowie die Einschätzung der palliativen Situation hängen stark vom vorliegenden Tumortyp ab. Die moderne Onkologie bietet neben den klassischen Therapieformen, bestehend aus chirurgischer Resektion mit anschließender Radiojodtherapie, weitere Optionen, wie Therapie mit Tyrosinkinaseinhibitoren bei entstandener Jodresistenz, an. Bei Beteiligung umliegender Organe treten frühzeitig Beeinträchtigungen wichtiger Lebensfunktionen auf. Drohender Autonomieverlust und Versorgungsbedürftigkeit der Patienten können präventive palliativchirurgische Maßnahmen notwendig machen, um die Lebensqualität der Patienten zu unterstützen. Art und Umfang chirurgischer Maßnahmen in dieser Grenzzone ist bei den verschiedenen Formen des Schilddrüsenkarzinoms unterschiedlich zu bewerten.
Article
Full-text available
Thyroid nodules are a common clinical problem, and differentiated thyroid cancer is becoming increasingly prevalent. Since the publication of the American Thyroid Association's guidelines for the management of these disorders was published in 2006, a large amount of new information has become available, prompting a revision of the guidelines. Relevant articles through December 2008 were reviewed by the task force and categorized by topic and level of evidence according to a modified schema used by the United States Preventative Services Task Force. The revised guidelines for the management of thyroid nodules include recommendations regarding initial evaluation, clinical and ultrasound criteria for fine-needle aspiration biopsy, interpretation of fine-needle aspiration biopsy results, and management of benign thyroid nodules. Recommendations regarding the initial management of thyroid cancer include those relating to optimal surgical management, radioiodine remnant ablation, and suppression therapy using levothyroxine. Recommendations related to long-term management of differentiated thyroid cancer include those related to surveillance for recurrent disease using ultrasound and serum thyroglobulin as well as those related to management of recurrent and metastatic disease. We created evidence-based recommendations in response to our appointment as an independent task force by the American Thyroid Association to assist in the clinical management of patients with thyroid nodules and differentiated thyroid cancer. They represent, in our opinion, contemporary optimal care for patients with these disorders.
Article
The objective of the study was to evaluate the efficacy of prophylactic neck dissection in the treatment of papillary thyroid cancer and to provide guidelines for clinical practice. Relevant clinical trials on prophylactic neck dissection in the treatment of papillary thyroid cancer were retrieved using PubMed, MEDLINE, EMBASE and Cochrane Controlled Trials Register until August 2012. Information was extracted according to the Cochrane systematic review methods. RevMan 5.0 was used for meta-analysis. Nine controlled clinical trials were included in this meta-analysis. Compared with patients who underwent thyroidectomy alone (control group), patients who underwent thyroidectomy plus prophylactic neck dissection (experimental group) showed a higher incidence of transient hypocalcemia (P = 0.02), but no significant changes were observed in the incidence of neck lymph node recurrence (P = 0.69), central neck lymph node recurrence (P = 0.61), lateral neck lymph node recurrence (P = 0.70), permanent hypocalcemia (P = 0.44), transient vocal cord paralysis (P = 0.13), permanent vocal cord paralysis (P = 0.26) and hematoma incidence (P = 0.39). Combined thyroidectomy and prophylactic neck dissection may be effective in the treatment of patients with papillary thyroid cancer, without more complications compared with thyroidectomy alone.
Article
Prophylactic central neck dissection (PCND) for papillary thyroid carcinoma (PTC) is controversial. We compared 3 different approaches to the management of central compartment nodes in patients with clinically unifocal and N0 PTC. A total of 186 patients were prospectively assigned to one of the following procedures: total thyroidectomy (TT), TT plus ipsilateral PCND (Ipsi-PCND), and TT plus bilateral PCND (Bil-PCND). No difference was found concerning demographic, clinical or pathologic characteristics (P = NS). More patients in the Bil-PCND group had transient hypocalcemia (P < .001). One patient in the Bil-PCND group experienced permanent hypoparathyroidism (P = NS). One transient and one permanent unilateral laryngeal nerve palsy occurred in the Ipsi-PCND group (P = NS). Significantly more patients in the Bil-PCND and Ipsi-PCND groups had node metastases recognized (26 vs 18 vs 6; P < .001). Six of 26 pN1 patients (23%) in the Bil-PCND group had bilateral metastases. No difference was found concerning mean postoperative basal and stimulated thyroglobulin and mean postoperative radioiodine uptake. One patient in the Ipsi-PCND group experienced recurrent disease (P = NS). TT seems adequate treatment for most patients with clinically N0 PTC. PCND could be considered for a more accurate staging. Ipsi-PCND could be a valid option, but it includes the risk of overlooking contralateral metastases.
Article
Prophylactic central neck dissection (CND) has been proposed in the treatment of patients affected by papillary thyroid carcinoma (PTC) with clinically negative neck lymph nodes. The procedure allows pathologic staging of lymph nodes of the central compartment and treatment of the micrometastases. Nevertheless, the morbidity that its routine use adds to the total thyroidectomy must be taken into account. The aim of this study was to characterize the morbidity that CND adds to the total thyroidectomy. This was a retrospective study of 1087 patients with PTC and clinically negative neck lymph nodes. Patients were divided into three study groups: Group A, total thyroidectomy; Group B, total thyroidectomy and ipsilateral CND; Group C, total thyroidectomy and bilateral CND. Primary endpoints of the study were evaluated by comparing the rates of transient and permanent recurrent laryngeal nerve (RLN) injury and hypoparathyroidism in the three study groups. Analysis of data showed no significant differences in the rate of transient (Group A: 3.6%, Group B: 3.9%, and Group C: 5.5%; p=0.404) and permanent (Group A: 1%, Group B: 0.5%, and Group C: 2.3%; p=0.099) RLN injury between the three study groups. Both ipsilateral CND and bilateral CND were associated with a higher rate of transient hypoparathyroidism (Group: A 27.7%, Group B: 36.1%, and Group C: 51.9%; p=0.014; odds ratio [OR]: 1.477; 95% confidence interval [CI]: 1.091-2.001; p<0.001; OR: 2.827; 95% CI: 2.065-3.870, respectively). Bilateral CND had a higher rate of permanent hypoparathyroidism (Group A: 6.3%, Group B: 7%, and Group C: 16.2%; p<0.001; OR: 2.860; 95% CI: 1.725-4.743). The increased rates of transient and permanent hypoparathyroidism in our series suggest a critical review of indications for the routine use of prophylactic CND for PTC. Prophylactic CND ipsilateral to the tumor associated with total thyroidectomy may represent an effective strategy for reducing the rate of permanent hypoparathyroidism. Concomitant completion contralateral paratracheal lymph node neck dissection should be performed in presence of lymph node metastasis on intraoperative frozen-section pathology. This approach limits the use of bilateral CND to patients with intraoperative pathological findings of lymph node metastases.
Article
Prophylactic central lymph node dissection with total thyroidectomy (TT) for the treatment of papillary thyroid cancer (PTC) is controversial because of the possibility of increased morbidity with uncertain benefit. The purpose of this study is to determine whether prophylactic central neck dissection provides any advantages over TT alone. Retrospective cohort study of patients with PTC without preoperative evidence of lymph node involvement undergoing either TT or TT with bilateral central lymph node dissection (TT + BCLND). From 2002 to 2009, 143 patients with clinically node-negative PTC underwent either TT (n = 65) or TT + BCLND (n = 78). The groups were similar in age, gender, tumor size, multifocality, angioinvasion, and metastasis/age/completeness-of-resection/invasion/size score. The presence of involved central neck lymph nodes upstaged 28.6% of patients in the TT + BCLND group to stage III disease, which resulted in higher radioactive iodine ablation doses. Stimulated serum thyroglobulin levels and the number of patients with undetectable stimulated thyroglobulin levels before and 1 year after radioactive iodine ablation were equivalent. The addition of routine central lymph node dissection to TT for the treatment of PTC upstages nearly one third of patients over the age of 45 thereby changing the dose of radioactive iodine ablative therapy, but does not change postoperative thyroglobulin levels after completion of radioiodine treatment.
Article
Intense disease surveillance and frequent lymph node metastases (LNMs) in papillary thyroid cancer (PTC) have resulted in increased locoregional recurrences. We examined the safety and efficacy of an optimized surgical approach including preoperative ultrasonography (US), bilateral thyroidectomy, routine compartment VI dissection, and lateral neck dissection for LNM. During 1999-2006, a total of 420 patients underwent optimized primary surgery; 291(69%) females, median age 46 years; follow-up 98%, median 4.4 years. Patients were reviewed for tumor characteristics, pattern of LNM, staging, and outcomes. Total or near-total thyroidectomy was performed in 212 (51%) and 208 (49%) patients, respectively. Tumors were multicentric, 40% (average 1.7 cm); were bilateral, 30%; and showed extrathyroidal extension, 17%. Overall, 223 (53%) patients had LNMs: 213 (51%) were central and 85 (20%) were lateral jugular. pTNM staging: I, 258 (61%); II, 35 (8%); III, 88 (21%); IV, 39 (9%). AGES (age, grade, extension, and size-thyroid tumor; and MACIS (metastasis, age, completeness of resection, invasion, and size) prognostic scores were low risk in 362 (86%) and 352 (84%), respectively. Relapse developed in 57 (14%) patients: LNM in 44, soft tissue local recurrence (LR) in 5, distant metastases (DM) in 8. Hypoparathyroidism occurred in 5 (1.2%) patients and 1 had unintentional laryngeal nerve damage. Relapse with LNM occurred in previously operated fields in 19 (5%) patients, 11(3%) from disease virulence (LR or DM), preoperative false-negative (FN) US in 12 (3%), and combination of FN-US and recurrence in the operated field in 5 (1%) patients. Recurrence was limited to 5% of patients when the extent of disease was accurately defined and potentially curable. This optimized surgical strategy is relatively safe.
Article
Many patients undergoing thyroidectomy for papillary thyroid carcinoma (PTC) have subclinical nodal disease at the time of surgery. Prophylactic bilateral central neck dissection (CND) is gaining acceptance in the treatment of PTC as studies have shown nodal disease increases the rate of local recurrence and may alter postsurgical radioactive iodine dosing. Given the potential complications of bilateral CND, we undertook a prospective study to determine the adequacy of prophylactic ipsilateral CND for PTC. A total of 116 patients with PTC underwent total thyroidectomy and routine prophylactic CND at a tertiary referral center. Of these, 45 had right and left central neck lymph node basins submitted separately for pathologic examination. We examined the laterality of positive lymph nodes based on tumor location and size. Overall, positive lymph nodes were found in 45% of patients. Of the patients having a lateralized CND, 33% had ipsilateral positive nodes only, while 20% had bilateral positive nodes. None of the patients with tumor size <=1 cm had bilateral positive lymph nodes compared with 31% of patients with tumors >1 cm (P = 0.02). Multifocality did not affect lymph node metastasis in tumors <=1 cm. Parathyroids were found in the pathology specimen of 34% of patients, 40% had parathyroids autotransplanted, 47% had temporary hypocalcemia, and 0% had permanent hypocalcemia. Rates of temporary and permanent recurrent laryngeal nerve injury were 5% and 0% respectively. Ipsilateral CND appears to be sufficient in patients with tumors <=1 cm. In tumors >1 cm, bilateral CND should be considered as these patients are more likely to have bilateral positive nodes. If tumor size is used as criteria for prophylactic CND, approximately one-third of patients can be spared a bilateral CND.